Fountainvest, TPG, WP among final bidders for Carlyle’s $1bn-targeting AmbioPharm exit

Carlyle is considering the final rounds of bids for its $1bn-targeting AmbioPharm exit from fellow buyout houses Fountainvest Capital Partners, TPG and Warburg Pincus, Reuters reported quoting sources.